301096 百誠醫藥
按盤價 
36.840 -0.970 (-2.565%)
36.840 -0.970 (-2.565%) | 2024/06 - 中期 | 2023/12 | 2022/12 | 2021/12 | 2020/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | 4.894 | 10.528 | 8.089 | 8.358 | 18.558 |
| 總資產報酬率 ROA (%) | 3.540 | 8.243 | 6.633 | 6.233 | 11.273 |
| 投入資產回報率 ROIC (%) | 3.814 | 8.966 | 7.062 | 6.632 | 12.862 | 邊際利潤分析 |
| 銷售毛利率 (%) | 68.752 | 65.528 | 67.373 | 67.265 | 65.813 |
| 營業利潤率 (%) | 25.510 | 29.193 | 31.057 | 31.789 | 31.253 |
| 息稅前利潤/營業總收入 (%) | 25.254 | 26.977 | 24.546 | 32.013 | 31.460 |
| 淨利潤/營業總收入 (%) | 25.553 | 26.735 | 31.946 | 29.646 | 27.597 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 104.531 | 102.449 | 90.733 | 96.330 | 85.081 |
| 價值變動淨收益/利潤總額(%) | 0.097 | -0.036 | -2.081 | -0.547 | 1.467 |
| 營業外收支淨額/利潤總額(%) | 0.122 | -0.454 | 1.185 | -0.035 | 0.557 | 償債能力分析 |
| 流動比率 (X) | 1.842 | 1.900 | 5.538 | 4.708 | 1.964 |
| 速動比率 (X) | 1.680 | 1.790 | 5.311 | 4.660 | 1.934 |
| 資產負債率 (%) | 28.419 | 26.845 | 15.273 | 20.756 | 0.468 |
| 帶息債務/全部投入資本 (%) | 20.978 | 15.212 | 3.570 | 12.664 | 34.942 |
| 股東權益/帶息債務 (%) | 359.982 | 529.979 | 2,540.417 | 662.769 | 165.420 |
| 股東權益/負債合計 (%) | 251.836 | 272.510 | 554.820 | 381.801 | 113.537 |
| 利息保障倍數 (X) | -88.002 | -12.943 | -3.566 | 135.989 | 978.968 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 94.943 | 61.820 | 67.053 | 53.508 | 53.260 |
| 存貨周轉天數 (天) | 134.664 | 81.715 | 80.748 | 38.888 | 15.595 |
| 備註： | 報價延遲最少15分鐘，資料更新時間為 20/08/2024 16:30 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
